Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines drive the growth of the influenza vaccine market.According to the report published by Allied Market Research, the global In...
/PRNewswire/ -- Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved...
Adding pembrolizumab to first-line treatment with lenvatinib did not improve outcomes in a phase 3 trial of patients with advanced HCC. Adding pembrolizumab to first-line treatment with lenvatinib did not improve outcomes in a phase 3 trial of patients with advanced HCC.
Mersana Therapeutics (NASDAQ:MRSN – Get Free Report) and Cocrystal Pharma (NASDAQ:COCP – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Insider & Institutional Ownership 13.4% of Cocrystal […]
IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vaccines based on its T-win® platform, announced today that the first patient has been dosed in its Phase 2 trial (NCT05280314) studying treatment with IO102-IO103 in combination with Merck’s ...